Lymph Node Ratio Predicts Recurrence in Patients with Papillary Thyroid Carcinoma with Low Lymph Node Yield.
lymph node ratio
lymph node yield
papillary thyroid carcinoma
recurrence
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
27 May 2023
27 May 2023
Historique:
received:
17
04
2023
revised:
24
05
2023
accepted:
25
05
2023
medline:
10
6
2023
pubmed:
10
6
2023
entrez:
10
6
2023
Statut:
epublish
Résumé
The American Thyroid Association risk stratification system suggests that having >5 metastatic lymph nodes (LNs) increase the recurrence risk in patients with papillary thyroid carcinoma (PTC). However, little is known about PTC with <5 harvested LNs. This study aimed to stratify patients with low-LN-yield (low-LNY) PTC based on lymph node ratios (LNRs). From 2007 to 2017, 6317 patients who underwent thyroidectomies were diagnosed with PTC at Seoul St. Mary's Hospital, and 909 patients with low LNYs were included in the study. Tumor recurrence was compared based on LNR. The LNR cutoff was determined using a receiver operating characteristic curve. Forty-six patients (5.1%) experienced recurrences over a mean follow-up period of 127.24 ± 33.6 months (range, 5-190 months). The cutoff for the low-LNR (
Identifiants
pubmed: 37296909
pii: cancers15112947
doi: 10.3390/cancers15112947
pmc: PMC10252081
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Endocr Connect. 2022 Feb 16;11(2):
pubmed: 35044932
Thyroid. 2012 Nov;22(11):1144-52
pubmed: 23083442
Thyroid. 2010 Nov;20(11):1235-45
pubmed: 21062195
Int J Endocrinol. 2022 Feb 28;2022:3534783
pubmed: 35265124
Surg Oncol. 2015 Jun;24(2):117-22
pubmed: 25956302
Am Surg. 2010 Jan;76(1):28-32
pubmed: 20135936
World J Surg. 2018 Mar;42(3):615-622
pubmed: 29349484
World J Surg. 2016 Jan;40(1):100-9
pubmed: 26578322
Front Endocrinol (Lausanne). 2020 May 15;11:265
pubmed: 32477264
Thyroid. 2016 Jan;26(1):1-133
pubmed: 26462967
Thyroid. 2022 May;32(5):560-570
pubmed: 35132899
BMC Cancer. 2019 Jun 25;19(1):622
pubmed: 31238891
Cancers (Basel). 2022 Jul 28;14(15):
pubmed: 35954338
Int J Surg. 2018 Feb;50:94-103
pubmed: 29329789
Otolaryngol Head Neck Surg. 2020 Jan;162(1):50-55
pubmed: 31661359
Cancer. 2017 Feb 1;123(3):372-381
pubmed: 27741354
PLoS One. 2015 Oct 02;10(10):e0139021
pubmed: 26431346
J Laryngol Otol. 2018 Jan;132(1):8-13
pubmed: 29122022
Clin Exp Otorhinolaryngol. 2018 Mar;11(1):58-64
pubmed: 29032663
Eur J Endocrinol. 2013 Jan 17;168(2):219-25
pubmed: 23161752
Laryngoscope. 2022 Sep;132(9):1883-1887
pubmed: 35229306
Int J Clin Exp Pathol. 2014 Aug 15;7(9):5393-403
pubmed: 25337182
J Pathol Transl Med. 2018 Sep;52(5):331-338
pubmed: 30157618
Ann Surg Oncol. 2013 Jun;20(6):1906-11
pubmed: 23263904
J Clin Oncol. 2016 Oct 1;34(28):3434-9
pubmed: 27528716
Clin Endocrinol (Oxf). 2015 Jul;83(1):124-32
pubmed: 25130203
Thyroid. 2009 Nov;19(11):1167-214
pubmed: 19860577
Lancet Diabetes Endocrinol. 2022 Apr;10(4):264-272
pubmed: 35271818
Oral Oncol. 2021 Dec;123:105567
pubmed: 34710736
Thyroid. 2013 Jul;23(7):811-6
pubmed: 23373961
Cancers (Basel). 2023 Jan 19;15(3):
pubmed: 36765580
Thyroid. 2016 Mar;26(3):434-40
pubmed: 26825749